Associate Program Director, Hematology/Oncology Fellowship
National Institutes of Health
Washington, DC, United States
Hematology and Oncology has emerged to become one of the most innovative and exciting fields in medicine. Particularly in recent years there has been a paradigm shift in cancer care and research toward targeting the interactions between cancer and the immune system to overcome challenges due to clonal evolution and drug resistance. My research is focused on i) improving supportive care for CLL patients, ii) assessing immunologic changes in CLL treated with novel oral therapies, and iii) assessing clonal dynamics with novel CLL therapies.
Positions:
Associate Program Director, Hematology/Oncology Fellowship
National Institutes of Health
Medical School:
Paracelsus Medical University, Austria (2007-2012)
Residency:
Cleveland Clinic, Ohio (2013-2016)
Fellowship:
National Institutes of Health, Maryland (2016-2019)
Board Certifications
Internal Medicine, Hematology, Oncology
Monday, October 9, 2023
10:45 AM – 11:00 AM EDT
